The pharmaceutical Contract Development Manufacturing Organisation (CDMO) market in Middle East & Africa is expected to reach a projected revenue of US$ 9,029.5 million by 2030. A compound annual growth rate of 5.2% is expected of Middle East & Africa pharmaceutical CDMO market from 2024 to 2030.
